Nutex Health Inc. NUTX
Nasdaq · XNAS · stock · Services-Business Services, NEC
Chart by TradingView
7/9
Piotroski F — financial health
4.62
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $875.3M | $70.8M | $444.3M | $245.6M | $423.4M |
| 2024 | $479.9M | $52.1M | $196.3M | $20.8M | $188.5M |
| 2023 | $247.6M | -$45.8M | $34.8M | -$8.2M | $79.1M |
| 2022 | $219.3M | -$424.8M | $15.4M | $36.0M | $120.3M |
| 2021 | $331.5M | $132.6M | $179.3M | $136.5M | $191.6M |
| 2020 | $274.0M | $106.0M | $157.6M | $25.5M | $147.4M |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 4.62 (safe)
- Working capital / assets 0.415
- Retained earnings / assets -0.312
- EBIT / assets 0.3
- Equity / liabilities 0.855
Source: SEC EDGAR filings · CIK 0001479681 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.